Patents Assigned to Theramax Inc.
  • Method for enhanced delivery of oxybutynin and compositions thereof
    Patent number: 6545046
    Abstract: This invention provides to a method for enhancement of systemic delivery of oxybutynin by administration via the nasal route, and methods of treatment comprising intranasal administration of oxybutynin. The present invention further provides pharmaceutical compositions comprising oxybutynin and/or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: April 8, 2003
    Assignee: Theramax Inc.
    Inventors: Amanda J. Sherratt, Abdulghan A. Houdi
  • Method for enhanced brain delivery of bupropion
    Patent number: 6150420
    Abstract: This invention provides to a method for enhancement of delivery of bupropion by administration via the nasal route, and methods of treatment comprising intranasal administration of bupropion. The present invention further provides pharmaceutical compositions comprising bupropion and/or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: November 21, 2000
    Assignee: Theramax, Inc.
    Inventors: Abdulghani A. Houdi, Anwar A. Hussain
  • Method for enhanced brain delivery of nicotinic antagonist
    Patent number: 6121289
    Abstract: This invention provides methods of treatment of addiction to tobacco comprising intranasal administration of nicotinic antagonists.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: September 19, 2000
    Assignee: Theramax, Inc.
    Inventor: Abdulghani A. Houdi